Stephen Finn

Has grant

Associate Professor

Trinity College Dublin School of Medicine

Ireland

Research Interests

Explore related searches

Professors in Ireland Professors in Cancer Biology Cancer Biology professors in Ireland

Contact this professor

ORCID

Google Scholar

Recent Grants

Grant: Close

Evasion of immune editing by circulating tumour cells is an exercise-modifiable mechanism underlying aggressive behaviour in obese men with prostate cancer

Open Date: 2014-04-01

Close Date: 2018-03-01

Articles (20)

Associations of prostate tumor immune landscape with vigorous physical activity and prostate cancer progression

Article Link

Year:

2024

Antibody–drug conjugates in lung and breast cancer: current evidence and future directions—a position statement from the ETOP IBCSG Partners Foundation

Article Link

Year:

2024

Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma

Article Link

Year:

2024

nf-core/circrna: a portable workflow for the quantification, miRNA target prediction and differential expression analysis of circular RNAs.

Article Link

Year:

2023

Lung Cancer in the Republic of Ireland

Article Link

Year:

2023

ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer

Article Link

Year:

2023

Genomic Landscape of NSCLC in the Republic of Ireland.

Article Link

Year:

2023

Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats

Article Link

Year:

2023

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma.

Article Link

Year:

2023

An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)

Article Link

Year:

2023

European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.

Article Link

Year:

2023

Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer

Article Link

Year:

2022

Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC

Article Link

Year:

2022

Incidence and Impact of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent.

Article Link

Year:

2022

Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.

Article Link

Year:

2022

Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort.

Article Link

Year:

2022

PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures

Article Link

Year:

2022

Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.

Article Link

Year:

2022

USO1 expression is dysregulated in non-small cell lung cancer.

Article Link

Year:

2022

Altered expression of ACOX2 in non-small cell lung cancer.

Article Link

Year:

2022

Collaborators (12)

Cathal O'Brien

Clinical Senior Lecturer

Trinity College Dublin

IRELAND

James J. Phelan

Trinity College Dublin

IRELAND

Lanshan Huang

Queen's University Belfast

UNITED KINGDOM

Noel E Donlon

Trinity College Dublin

IRELAND

Luka Brcic

Medical University of Graz

AUSTRIA

Pilib Ó Broin

University of Galway

IRELAND

Emanuela Felley‐Bosco

SWITZERLAND

Anne-Marie Baird

Trinity College Dublin

IRELAND

Teodora Radonic

Amsterdam University Medical Centers

NETHERLANDS

Martin Barr

Clinical Senior Lecturer

Trinity College Dublin

IRELAND

Joanne Lysaght

Professor

Trinity College Dublin

IRELAND

Kathy Gately

Clinical Senior Lecturer

Trinity College Dublin

IRELAND

Stephen Finn

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Associations of prostate tumor immune landscape with vigorous physical activity and prostate cancer progression

Antibody–drug conjugates in lung and breast cancer: current evidence and future directions—a position statement from the ETOP IBCSG Partners Foundation

Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma

nf-core/circrna: a portable workflow for the quantification, miRNA target prediction and differential expression analysis of circular RNAs.

Lung Cancer in the Republic of Ireland

ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer

Genomic Landscape of NSCLC in the Republic of Ireland.

Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma.

An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)

European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.

Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer

Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC

Incidence and Impact of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent.

Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.

Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort.

PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures

Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.

USO1 expression is dysregulated in non-small cell lung cancer.

Altered expression of ACOX2 in non-small cell lung cancer.

Collaborators (12)

Cathal O'Brien

James J. Phelan

Lanshan Huang

Noel E Donlon

Luka Brcic

Pilib Ó Broin

Emanuela Felley‐Bosco

Anne-Marie Baird

Teodora Radonic

Martin Barr

Joanne Lysaght

Kathy Gately

How do I reach out?

Meet Kite AI